• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养物质诱导的SCFβ-TRCP介导的FNIP降解调控卵泡抑素相关蛋白复合体定位并促进肾癌进展。

Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.

作者信息

Nagashima Katsuyuki, Fukushima Hidefumi, Shimizu Kouhei, Yamada Aya, Hidaka Masumi, Hasumi Hisashi, Ikebe Tetsuro, Fukumoto Satoshi, Okabe Koji, Inuzuka Hiroyuki

机构信息

Center for Advanced Stem Cell and Regenerative Research, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan.

Department of Physiological Sciences and Molecular Biology, Fukuoka Dental College, Fukuoka 814-0193, Japan.

出版信息

Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221.

DOI:10.18632/oncotarget.14221
PMID:28039480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354783/
Abstract

Folliculin-interacting protein 1 and 2 (FNIP1 and FNIP2) play critical roles in preventing renal malignancy through their association with the tumor suppressor FLCN. Mutations in FLCN are associated with Birt-Hogg-Dubé (BHD) syndrome, a rare disorder with increased risk of renal cancer. Recent studies indicated that FNIP1/FNIP2 double knockout mice display enlarged polycystic kidneys and renal carcinoma, which phenocopies FLCN knockout mice, suggesting that these two proteins function together to suppress renal cancer. However, the molecular mechanism functionally linking FNIP1/FNIP2 and FLCN remains largely elusive. Here, we demonstrated that FNIP2 protein is unstable and subjected to proteasome-dependent degradation via β-TRCP and Casein Kinase 1 (CK1)-directed ubiquitination in a nutrition-dependent manner. Degradation of FNIP2 leads to lysosomal dissociation of FLCN and subsequent lysosomal association of mTOR, which in turn promotes the proliferation of renal cancer cells. These results indicate that SCFβ-TRCP negatively regulates the FLCN complex by promoting FNIP degradation and provide molecular insight into the pathogenesis of BHD-associated renal cancer.

摘要

卵泡素相互作用蛋白1和2(FNIP1和FNIP2)通过与肿瘤抑制因子FLCN结合,在预防肾恶性肿瘤中发挥关键作用。FLCN的突变与Birt-Hogg-Dubé(BHD)综合征相关,这是一种患肾癌风险增加的罕见疾病。最近的研究表明,FNIP1/FNIP2双敲除小鼠表现出多囊肾增大和肾癌,这与FLCN敲除小鼠的表型相似,表明这两种蛋白共同发挥作用抑制肾癌。然而,在功能上连接FNIP1/FNIP2和FLCN的分子机制仍 largely难以捉摸。在这里,我们证明FNIP2蛋白不稳定,并通过β-TRCP和酪蛋白激酶1(CK1)指导的泛素化以营养依赖的方式进行蛋白酶体依赖性降解。FNIP2的降解导致FLCN的溶酶体解离以及随后mTOR的溶酶体结合,进而促进肾癌细胞的增殖。这些结果表明,SCFβ-TRCP通过促进FNIP降解对FLCN复合物产生负调控,并为BHD相关肾癌的发病机制提供了分子见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/ece92d59e67d/oncotarget-08-9947-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/f50ffc82569b/oncotarget-08-9947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/8fdfa3563273/oncotarget-08-9947-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/7446f8701842/oncotarget-08-9947-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/df9e47b0ef1c/oncotarget-08-9947-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/88a3ff6ccc56/oncotarget-08-9947-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/7b5b79b8eda8/oncotarget-08-9947-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/ece92d59e67d/oncotarget-08-9947-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/f50ffc82569b/oncotarget-08-9947-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/8fdfa3563273/oncotarget-08-9947-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/7446f8701842/oncotarget-08-9947-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/df9e47b0ef1c/oncotarget-08-9947-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/88a3ff6ccc56/oncotarget-08-9947-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/7b5b79b8eda8/oncotarget-08-9947-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a5/5354783/ece92d59e67d/oncotarget-08-9947-g007.jpg

相似文献

1
Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.营养物质诱导的SCFβ-TRCP介导的FNIP降解调控卵泡抑素相关蛋白复合体定位并促进肾癌进展。
Oncotarget. 2017 Feb 7;8(6):9947-9960. doi: 10.18632/oncotarget.14221.
2
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.Birt-Hogg-Dubé综合征:新发现的肾癌综合征的临床和分子学特征
Int J Urol. 2016 Mar;23(3):204-10. doi: 10.1111/iju.13015. Epub 2015 Nov 25.
3
Interaction of folliculin (Birt-Hogg-Dubé gene product) with a novel Fnip1-like (FnipL/Fnip2) protein.卵泡抑素(Birt-Hogg-Dubé基因产物)与一种新型Fnip1样(FnipL/Fnip2)蛋白的相互作用。
Oncogene. 2008 Sep 11;27(40):5339-47. doi: 10.1038/onc.2008.261. Epub 2008 Jul 28.
4
Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.卵泡抑素相互作用蛋白Fnip1和Fnip2与Flcn协同作用,在肾肿瘤抑制中发挥关键作用。
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1624-31. doi: 10.1073/pnas.1419502112. Epub 2015 Mar 16.
5
Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.与 Birt-Hogg-Dubé 综合征相关的卵泡抑素变体被靶向进行蛋白酶体降解。
PLoS Genet. 2020 Nov 2;16(11):e1009187. doi: 10.1371/journal.pgen.1009187. eCollection 2020 Nov.
6
Identification and characterization of a novel folliculin-interacting protein FNIP2.一种新型卵泡抑素相互作用蛋白FNIP2的鉴定与表征
Gene. 2008 May 31;415(1-2):60-7. doi: 10.1016/j.gene.2008.02.022. Epub 2008 Mar 4.
7
The folliculin-FNIP1 pathway deleted in human Birt-Hogg-Dubé syndrome is required for murine B-cell development.人类 Birt-Hogg-Dubé 综合征中缺失的滤泡素-FNIP1 通路对于小鼠 B 细胞发育是必需的。
Blood. 2012 Aug 9;120(6):1254-61. doi: 10.1182/blood-2012-02-410407. Epub 2012 Jun 18.
8
Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.由BHD基因编码的卵泡抑素与一种结合蛋白FNIP1和AMPK相互作用,并参与AMPK和mTOR信号传导。
Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15552-7. doi: 10.1073/pnas.0603781103. Epub 2006 Oct 6.
9
Renal tumour suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin.滤泡素抑瘤功能与 Birt-Hogg-Dubé 综合征基因产物。
J Med Genet. 2010 Mar;47(3):182-9. doi: 10.1136/jmg.2009.072009. Epub 2009 Oct 19.
10
Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia.小鼠肾脏中FLCN的缺乏导致多囊肾和肾肿瘤的发生。
PLoS One. 2008;3(10):e3581. doi: 10.1371/journal.pone.0003581. Epub 2008 Oct 30.

引用本文的文献

1
Familial multiple discoid fibromas is linked to a locus on chromosome 5 including the FNIP1 gene.家族性多发性盘状纤维瘤与5号染色体上包括FNIP1基因的一个基因座相关联。
J Hum Genet. 2023 Apr;68(4):273-279. doi: 10.1038/s10038-022-01113-1. Epub 2023 Jan 4.
2
An mTORC1-mediated negative feedback loop constrains amino acid-induced FLCN-Rag activation in renal cells with TSC2 loss.mTORC1 介导的负反馈回路限制了 TSC2 缺失的肾细胞中氨基酸诱导的 FLCN-Rag 激活。
Nat Commun. 2022 Nov 10;13(1):6808. doi: 10.1038/s41467-022-34617-7.
3
Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.

本文引用的文献

1
Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.通过汇聚性基因组生物标志物发现克服肿瘤异质性带来的治疗障碍:肾癌的辫状癌河模型
Semin Cell Dev Biol. 2017 Apr;64:98-106. doi: 10.1016/j.semcdb.2016.09.002. Epub 2016 Sep 8.
2
Mutation of Fnip1 is associated with B-cell deficiency, cardiomyopathy, and elevated AMPK activity.Fnip1基因的突变与B细胞缺陷、心肌病以及AMPK活性升高有关。
Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3706-15. doi: 10.1073/pnas.1607592113. Epub 2016 Jun 14.
3
Folliculin directs the formation of a Rab34-RILP complex to control the nutrient-dependent dynamic distribution of lysosomes.
Hsp90 与癌症的 Tsc1 和 FNIP 共伴侣之间新的联系。
Biomolecules. 2022 Jul 1;12(7):928. doi: 10.3390/biom12070928.
4
Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation.与 Birt-Hogg-Dubé 综合征相关的卵泡抑素变体被靶向进行蛋白酶体降解。
PLoS Genet. 2020 Nov 2;16(11):e1009187. doi: 10.1371/journal.pgen.1009187. eCollection 2020 Nov.
5
FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.FLCN 改变驱动唾液腺核苷酸合成和囊泡形成的代谢重编程。
Biochem Biophys Res Commun. 2020 Feb 19;522(4):931-938. doi: 10.1016/j.bbrc.2019.11.184. Epub 2019 Dec 2.
6
Folliculin Interacting Protein 1 Maintains Metabolic Homeostasis during B Cell Development by Modulating AMPK, mTORC1, and TFE3.卵泡抑素相互作用蛋白 1 通过调节 AMPK、mTORC1 和 TFE3 维持 B 细胞发育过程中的代谢稳态。
J Immunol. 2019 Dec 1;203(11):2899-2908. doi: 10.4049/jimmunol.1900395. Epub 2019 Nov 1.
7
Control of mTOR signaling by ubiquitin.泛素对 mTOR 信号的调控。
Oncogene. 2019 May;38(21):3989-4001. doi: 10.1038/s41388-019-0713-x. Epub 2019 Jan 31.
8
BHD-associated kidney cancer exhibits unique molecular characteristics and a wide variety of variants in chromatin remodeling genes.BHD 相关性肾癌表现出独特的分子特征和广泛的染色质重塑基因变异。
Hum Mol Genet. 2018 Aug 1;27(15):2712-2724. doi: 10.1093/hmg/ddy181.
9
FLCN: The causative gene for Birt-Hogg-Dubé syndrome.FLCN:Birt-Hogg-Dubé综合征的致病基因。
Gene. 2018 Jan 15;640:28-42. doi: 10.1016/j.gene.2017.09.044. Epub 2017 Sep 29.
10
Control of B lymphocyte development and functions by the mTOR signaling pathways.mTOR信号通路对B淋巴细胞发育和功能的调控
Cytokine Growth Factor Rev. 2017 Jun;35:47-62. doi: 10.1016/j.cytogfr.2017.04.005. Epub 2017 May 22.
卵泡抑素引导Rab34-RILP复合物的形成,以控制溶酶体依赖营养物质的动态分布。
EMBO Rep. 2016 Jun;17(6):823-41. doi: 10.15252/embr.201541382. Epub 2016 Apr 13.
4
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.TSC1、TSC2和MTOR基因的突变与转移性肾细胞癌患者对雷帕霉素类似物的反应相关。
Clin Cancer Res. 2016 May 15;22(10):2445-2452. doi: 10.1158/1078-0432.CCR-15-2631. Epub 2016 Feb 1.
5
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.Birt-Hogg-Dubé综合征:新发现的肾癌综合征的临床和分子学特征
Int J Urol. 2016 Mar;23(3):204-10. doi: 10.1111/iju.13015. Epub 2015 Nov 25.
6
Clinical Features, Genetics and Potential Therapeutic Approaches for Birt-Hogg-Dubé Syndrome.Birt-Hogg-Dubé综合征的临床特征、遗传学及潜在治疗方法
Expert Opin Orphan Drugs. 2015;3(1):15-29. doi: 10.1517/21678707.2014.987124. Epub 2014 Nov 29.
7
Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression.缺乏卵泡抑素的肾细胞具有致瘤性且对mTOR抑制敏感。
Oncotarget. 2015 Oct 20;6(32):32761-73. doi: 10.18632/oncotarget.5018.
8
Regulation of mTORC1 by PI3K signaling.PI3K信号通路对mTORC1的调控。
Trends Cell Biol. 2015 Sep;25(9):545-55. doi: 10.1016/j.tcb.2015.06.002. Epub 2015 Jul 6.
9
Disruption of tubular Flcn expression as a mouse model for renal tumor induction.破坏管状 Flcn 表达作为诱导肾肿瘤的小鼠模型。
Kidney Int. 2015 Nov;88(5):1057-69. doi: 10.1038/ki.2015.177. Epub 2015 Jun 17.
10
Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.卵泡抑素相互作用蛋白Fnip1和Fnip2与Flcn协同作用,在肾肿瘤抑制中发挥关键作用。
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):E1624-31. doi: 10.1073/pnas.1419502112. Epub 2015 Mar 16.